120 related articles for article (PubMed ID: 34525177)
41. Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma.
Qin W; Fu D; Shi Q; Dong L; Yi H; Huang H; Jiang X; Song Q; Liu Z; Cheng S; Huang J; Wang L; Xu P; Zhao W
Front Oncol; 2021; 11():638757. PubMed ID: 34557402
[TBL] [Abstract][Full Text] [Related]
42. Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.
Olszewski AJ; Chorzalska AD; Petersen M; Ollila TA; Zayac A; Kurt H; Treaba DO; Reagan JL; Hsu A; Egan PC; Butera J; Niroula R; Vatkevich J; Robison J; Sahin I; Jacob AP; Mullins CD; Dubielecka PM
Blood Adv; 2021 Dec; 5(24):5525-5535. PubMed ID: 34551072
[TBL] [Abstract][Full Text] [Related]
43. BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified.
Marques-Piubelli ML; Solis LM; Parra ER; Castillo LM; Gouni S; Nair R; Chihara D; Konopleva M; Wistuba II; Iyer SP; Vega F; Strati P
Blood Cancer J; 2021 Sep; 11(9):153. PubMed ID: 34531377
[No Abstract] [Full Text] [Related]
44. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.
Amaya ML; Inguva A; Pei S; Jones C; Krug A; Ye H; Minhajuddin M; Winters A; Furtek SL; Gamboni F; Stevens B; D'Alessandro A; Pollyea DA; Reigan P; Jordan CT
Blood; 2022 Jan; 139(4):584-596. PubMed ID: 34525179
[TBL] [Abstract][Full Text] [Related]
45. Primary CNS lymphoma in Immunocompetent patients: Appearances on Conventional and Advanced Imaging with Review of literature.
Joshi A; Deshpande S; Bayaskar M
J Radiol Case Rep; 2022 Jul; 16(7):1-17. PubMed ID: 36051362
[TBL] [Abstract][Full Text] [Related]
46. Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.
Woroniecka R; Rymkiewicz G; Szafron LM; Blachnio K; Szafron LA; Bystydzienski Z; Pienkowska-Grela B; Borkowska K; Rygier J; Kotyl A; Malawska N; Wojtkowska K; Parada J; Borysiuk A; Murcia Pienkowski V; Rydzanicz M; Grygalewicz B
PLoS One; 2022; 17(2):e0263980. PubMed ID: 35167621
[TBL] [Abstract][Full Text] [Related]
47. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wilson WH; Wright GW; Huang DW; Hodkinson B; Balasubramanian S; Fan Y; Vermeulen J; Shreeve M; Staudt LM
Cancer Cell; 2021 Dec; 39(12):1643-1653.e3. PubMed ID: 34739844
[TBL] [Abstract][Full Text] [Related]
48. PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphoma.
Mondello P; Ansell SM
Cancer Cell; 2021 Dec; 39(12):1570-1572. PubMed ID: 34739842
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
50. NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
Alderuccio JP; Lossos IS
Leuk Lymphoma; 2022 Feb; 63(2):279-290. PubMed ID: 34586000
[TBL] [Abstract][Full Text] [Related]
51. Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma.
Garcia-Marquez MA; Thelen M; Reinke S; Keller D; Wennhold K; Lehmann J; Veldman J; Borchmann S; Rosenwald A; Sasse S; Diepstra A; Borchmann P; Engert A; Klapper W; von Bergwelt-Baildon M; Bröckelmann PJ; Schlößer HA
Leukemia; 2022 Mar; 36(3):760-771. PubMed ID: 34584203
[TBL] [Abstract][Full Text] [Related]
52. PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.
Liu F; Gao Y; Xu B; Xiong S; Yi S; Sun J; Chen Z; Liu X; Li Y; Lin Y; Wen Y; Qin Y; Yang S; Li H; Tejasvi T; Tsoi L; Tu P; Ren X; Wang Y
Blood; 2022 Jan; 139(4):554-571. PubMed ID: 34582557
[TBL] [Abstract][Full Text] [Related]
53. Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes.
Nogueira DS; Lage LAPC; Culler HF; Pereira J
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):67-75. PubMed ID: 34580043
[TBL] [Abstract][Full Text] [Related]
54. Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment.
Pileri SA; Tabanelli V; Fiori S; Calleri A; Melle F; Motta G; Lorenzini D; Tarella C; Derenzini E
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572763
[TBL] [Abstract][Full Text] [Related]
55. Functioning of the International Health Regulations during the COVID-19 pandemic.
Aavitsland P; Aguilera X; Al-Abri SS; Amani V; Aramburu CC; Attia TA; Blumberg LH; Chittaganpitch M; Le Duc JW; Li D; Mokhtariazad T; Moussif M; Ojo OE; Okwo-Bele JM; Saito T; Sall AA; Salter MWAP; Sohn M; Wieler LH
Lancet; 2021 Oct; 398(10308):1283-1287. PubMed ID: 34570995
[No Abstract] [Full Text] [Related]
56. Follicular lymphoma and macrophages: impact of approved and novel therapies.
Gouni S; Marques-Piubelli ML; Strati P
Blood Adv; 2021 Oct; 5(20):4303-4312. PubMed ID: 34570196
[TBL] [Abstract][Full Text] [Related]
57. Intergenerational inequities in exposure to climate extremes.
Thiery W; Lange S; Rogelj J; Schleussner CF; Gudmundsson L; Seneviratne SI; Andrijevic M; Frieler K; Emanuel K; Geiger T; Bresch DN; Zhao F; Willner SN; Büchner M; Volkholz J; Bauer N; Chang J; Ciais P; Dury M; François L; Grillakis M; Gosling SN; Hanasaki N; Hickler T; Huber V; Ito A; Jägermeyr J; Khabarov N; Koutroulis A; Liu W; Lutz W; Mengel M; Müller C; Ostberg S; Reyer CPO; Stacke T; Wada Y
Science; 2021 Oct; 374(6564):158-160. PubMed ID: 34565177
[TBL] [Abstract][Full Text] [Related]
58. A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients.
Calvani J; Gérard L; Fadlallah J; Poullot E; Galicier L; Robe C; Garzaro M; Bertinchamp R; Boutboul D; Cuccuini W; Cayuela JM; Gaulard P; Oksenhendler É; Meignin V
Am J Surg Pathol; 2022 Mar; 46(3):353-362. PubMed ID: 34560683
[TBL] [Abstract][Full Text] [Related]
59. Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.
Forlenza CJ; Gulati N; Mauguen A; Absalon MJ; Castellino SM; Franklin A; Keller FG; Shukla N
Blood Adv; 2021 Dec; 5(24):5519-5524. PubMed ID: 34559223
[TBL] [Abstract][Full Text] [Related]
60. Myelodysplastic Syndromes: A New Decade.
Volpe VO; Garcia-Manero G; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):1-16. PubMed ID: 34544674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
